The global infusion pump market size was USD 12.80 Billion in 2021, and is expected to register a revenue CAGR of 9.4% during the forecast period. Rising prevalence of different cancers, diabetes, and other chronic diseases requiring intravenous treatment, and increasing adoption of infusion pumps for post-surgery analgesics are some major factors expected to drive market revenue growth during the forecast period. Rapid implementation of advanced technologies in infusion pumps is another factor expected to drive revenue growth of the market over the forecast period.
Infusion pumps are medical devices that allow patients to receive drugs in a controlled manner. It regulates amount of fluids supplied, and is used for delivering large and micro amounts of nutrition and medicinal formulations, such as insulin or other hormones, antibiotics, chemotherapeutic drugs, and pain relievers. This pump is used in clinical settings, such as hospitals, nursing homes, and even in home settings by patients suffering from chronic diseases such as cancers to receive intravenous treatment. According to the World Health Organization (WHO), about 10 million people died from cancer in 2020. Chemotherapy, which is a viable therapeutic option for patients of the disease, is done through intravenous drug delivery, which requires infusion pumps. Demand for the device is increasing in medical centers for delivering pain-relieving drugs in patients having post-operational pain, which is expected to drive revenue growth of the global infusion pump market. According to Infusion Nurses Society, an estimated 90% hospitalized patients require intravenous delivery of fluids or drugs through IV infusion pumps. Smart components, such as open and closed-loop systems, touchscreen, microprocessors, stepper motors, low-dropout linear regulators, display/keyboard, monitoring systems, and occlusion alarms, are widely used for smooth, fast, and efficient treatment. The technology also enables healthcare providers to control pump parameters remotely thus increasing scope of interoperability.
Request a Sample@ https://qyresearchmedical.com/sample/119103
Adoption of ambulatory infusion pumps is expected to increase in various healthcare and emergency centers due to low cost and portability of the devices. Technological advancements and innovation in medical equipment has enabled healthcare providers to regulate amount of nutrients or medicinal formulations administered to patient through the use of pumps, which is expected to increase adoption of such devices and instruments in the healthcare sector. The pumps are used in a wide range of operations, including monitoring time interval to inject fluid, air detection, and pressure control, as well as their cassette and peristaltic pumping technique and user-alert feature. This enables doctors and clinicians to control rate of nutrient uptake in body of the patient. Increase in number surgeries performed globally has resulted in increased demand for Patient-Controlled Analgesia (PCA) infusion pumps, which allows patients to self-administer controlled amount of pain-relieving medication. Infusion pumps can also provide large or tiny volume of fluids, as well as nutrition, resulting in their increasing adoption in healthcare facilities. Increasing use of these pumps in busy hospital environments for reducing human errors, and alerting staff if anything deviates from defined parameters and protecting patients from any loss is another major factor expected to drive revenue growth of the global market. Infusion pumps are available in different types, which allows a wide range of operations across several healthcare facilities, which is further expected to increase their adoption over the forecast period. Applications of these pumps are widely diverse, and they are used by physicians for delivering liquid food, morphine and other pain-relieving drugs, and antibiotics. Parts of infusion pumps are easily replaceable reducing repair time and longevity of the equipment.
Driver: Increasing adoption of infusion pumps for treatment of chronic diseases is a major factor driving market revenue growth
Infusion pumps are used for treatment of various diseases, including cancer, diabetes, iron poisoning, and thromboembolic disease, which is increasing adoption of medical devices in the healthcare sector. The pump delivers medications, drugs, or nutrients, according to the disease, into the body of patient. For instance, during cancer treatment chemotherapy formulations are administered into the patient body through Intravenous (IV) infusion pumps. The device software controls user interface, manages pumping mechanism to maintain prescribed infusion rate, and performs important safety functions to make the device safer and easier to use. Patients of type-1 diabetes need to inject insulin externally at regular intervals to maintain normal blood glucose levels. Automated infusion pumps eliminate need of a medical assistant, thus cutting down medical costs of patients, and accurately inject the hormone according to dosage and interval prescribed by the healthcare provider.
Digital technology has revolutionized medicaments in recent years, as machinery is being increasingly manufactured with programming capabilities. These technologies enable devices to perform surgical procedures with minimal human involvement. Furthermore, Internet-of-Things (IoT) has increased interoperability among different healthcare centers, thereby reducing time of diagnosis and accelerated treatment process. Moreover, machinery used for treatment is improving with the latest upgraded technologies, such as static code analysis, which is widely used for verifying correctness of programming codes. This technology also helps in full-scale testing of the system in which the software is installed. Other technologies, such as model-based software development, are widely used during manufacturing to develop a set of safety models. These technologies are valuable for a range of different generic infusion pump projects, and is improving robustness of the device software to prevent potential cyberattacks. This is increasing demand for infusion pumps and is expected to drive revenue growth of the market between 2022 and 2030.
Restraint: Defects in infusion pumps resulting in bulk recalls and cybersecurity flaws are expected to restrain market revenue growth
Infusion pumps are primarily used for administration of essential fluids, such as glucose and other nutrients, and high-risk formulations, hence errors in the usage of these devices can lead to adverse medical effects, major injury to patients, and even death. In 2020, The U.S. Food and Drug Administration (FDA) announced Class I recall of Becton Dickinson Alaris System infusion pumps due to reports of injuries and death. In the past as well, the FDA recorded recall of infusion pumps in bulk amounts due to several defects, including software defects, issues related to user interface, and electrical and mechanical failures. Software problems include malfunctioning of pre-programmed alarms, which are installed to indicate any technical problem. Failure of alarm activation in case of a problem and activation in absence of problems leads to a significant number of false-positive and true-negative reports. Moreover, the FDA received several Medical Device Reports (MDRs) in the past few years related to irregular fluid flow continuity in syringe pumps, which can result in severe medical issues, such as delay in therapy, unstable blood pressure, anxiety due to loss of sedative dose, and over- or under-infusion. Infusion and syringe pumps operating at low rate of infusion (less than 5mL per hour) have displayed such problems, and it is expected to hamper market revenue growth to a certain extent.
Studies published in the National Centre for Biotechnology Information (NCBI) reported increased risk to patient safety upon use of infusion pumps due to complexity and multiple number of steps involved in operating the devices. Around 54% of the total number of adverse drug events, 56% medication errors, and 61% life-threatening errors have been caused due to Intravenous (IV) infusions. Moreover, studies published in March 2022, have found major cybersecurity flaws in infusion pump software of several healthcare facilities that makes the devices increasingly vulnerable to cyberattacks. More than 70% of the pumps, which account for around 35% of the Internet-of-Things (IoT) footprint of a hospital have cyber vulnerabilities, which increases the data breach and data theft risks, and is expected to hamper revenue growth of the market to a considerable extent.
The global infusion pumps market has recovered to a significant extent after experiencing a setback due to the pandemic. In 2020, the U.S. FDA issued Emergency Use Authorization (EUAs) for infusion pumps to enable increased availability of the medical device in hospitals and healthcare centers where it is used to treat COVID-19 patients. Use of remote monitoring and remote manual-control feature infusion pumps has enabled Healthcare Providers (HCPs) to maintain safe distance from patients during treatment, thereby reducing risk of infection. Furthermore, FDA issued individual EUAs for products of particular companies to reduce infection rates in HCPs after reviewing long-term benefits of using the devices for treatment. Outlook Pumps of B. Braun Medical, Inc. received authorization to be used in medical centers by the regulatory body in April 2020. The pumps deliver continuous nebulized medications in the trachea of patients through nebulizers used in conjunction with infusion pumps. The devices can be used wirelessly and pump infusion parameters can be auto-programmed remotely by technicians, thus increasing adoption of COVID-19 treatment. In addition, in June 2020, the World Health Organization issued ‘COVID-19 Technical Specifications for Infusion Devices’, which outlined standards and parameter ranges for use of infusion pumps and associated devices. Manufacturers in several countries in the Europe ramped up production of the devices by 20-30% during the pandemic. Partnerships among manufacturers and end-users increased as well, for operational and technical training. However, shortages in infusion pump supply was experienced around the globe in 2020. This is due to rapid use of IV infusion pumps and other pumps for treatment of COVID-19 patients, which significantly increased demand-supply gap.
Product Type Outlook:
Based on product type, the global infusion pump market has been segmented into devices, and consumables and accessories. Devices segment is further sub-segmented into portable infusion pumps, stationary infusion pumps, elastomeric infusion pumps, specialty infusion pumps, traditional infusion pumps, implantable infusion pumps, ambulatory infusion pumps, PCA pumps, syringe infusion pumps, insulin pumps, enteral infusion pumps, and volumetric infusion pumps. Consumables and accessories segment is further sub-segmented into dedicated consumables and accessories, and non-dedicated consumables and accessories.
Devices segment is expected to account for a considerably large revenue share over the forecast period. Revenue growth of this segment is being driven by increasing use of specialized infusion pumps for drug delivery to patients rather than oral treatment. Specialty infusion pumps aid in reduction of chronic illnesses and disorders through continuous and regulated supply of drugs, which is increasing adoption of the device by patients of diseases such as diabetes, where it is used for periodic administration of insulin. According to clinical overviews published in the NCBI, out of the total patient pool using the pumps, around 60% suffer from type-1 diabetes and 10% from type-2 diabetes, and number of T2D patients using insulin pumps is increasing. This is expected to drive revenue growth of the segment.
Elastomeric infusion pump sub-segment is expected to register a steady revenue growth rate over the forecast period. Rising demand for sustainable infusion pumps and increasing use of monolayer or multilayer elastomeric membrane in elastomeric pumps is increasing adoption of elastomeric membrane in healthcare centers, which is expected to drive revenue growth of this segment. Observational studies conducted in the recent past have concluded that antibiotic treatment of patients with Elastomeric Infusion Pumps (EIPs) over a 24-month period has aided in significantly reducing medical costs with a cure rate of 84%.
Consumables and accessories segment is expected to register a significantly rapid revenue growth rate over the forecast period. Enteral infusion pumps have been increasingly used for delivering liquid nutrients and medications to the gastrointestinal tract of patients who cannot ingest food. Delivering liquid nutrients through enteral pump is a safe, efficacious, and acceptable process. There are various types of enteral pumps for different uses, such as tube feedings pumps and cycle feeding pumps. The device allows both continuous and intermittent administration of nutrients at a controlled rate based on diet of the patient. Increasing number of medical complications resulting in mobility problems and feeding issues in geriatric patients is increasing adoption of enteral pumps as well as cannulas, which is expected to drive revenue growth of this segment.
Based on application, the global infusion pump market has been segmented into pain management, neonatology, oncology, hematology, diabetes management, gastroenterology, and others. Pain management segment is expected to account for a larger revenue share in the global infusion pump market over the forecast period. Demand for Patient-Controlled Analgesia (PCA) pumps is increasing in hospitals and medical centers to provide relief for post-operative pain. Improvements in analgesic technologies to relief surgical pain is increasing adoption of PCA pumps and expected to drive revenue growth of this segment.
Neonatal infusion pumps have increased regulation over rate of infusion, to administer nutrients and medications at very controlled levels in newborn children. Increasing adoption of devices in pediatric centers to relieve pain in neonatal patients suffering from medical complications is expected drive revenue growth of this segment over the forecast period.
Based on material, the global infusion pump market has been segmented into battery, piston seal, needleless connectors, BLDC motor, barrel, catheter connector, check valve seal, electronic hybrid module, and others. Battery segment is expected to account for a considerably large revenue share over the forecast period. Increasing use of Nickel-Cadmium (NI-CD) batteries in infusion pump operation is increasing their demand, which is expected to drive revenue growth of this segment. Rising adoption of rigid, easy to handle, and convenient transportation materials is leading to rising demand for infusion pumps. Other factors, such as continuous recyclability, reliability, and durability are expected to increase demand for battery use and drive revenue growth of this segment. Rapid growth of the battery manufacturing industry is also expected to have a positive impact on revenue growth of this segment.
Based on regional analysis, the market in North America is expected to account for largest revenue share in the global market during the forecast period. Rapid growth of the healthcare industry is expected to increase demand for infusion pumps among healthcare providers in countries in the region. According to WHO statistics, as of May 2022, about 81 million cases of COVID-19 have been recorded in the U.S. This is expected to increase adoption of automated IV pumps for treatment of COVID-19 patients. Moreover, rapid implementation of advanced technologies in infusion pumps by manufacturers operating in countries, such as the U.S., Canada, and Mexico is another major factor expected to drive revenue growth of the North America infusion pump market.
The market in Europe is expected to register a steady revenue CAGR over the forecast period. Increase in prevalence of chronic diseases in countries, such as the U.K, Germany, Spain, Italy, Russia, and others, is expected to increase demand for infusion pumps. Moreover, rising demand for portable infusion pumps to reduce hospital stays is expected to drive revenue growth of the market in the near future. In 2022, Ukraine received USD 10.4 million worth of medical stockpile from rescEU, which included infusion pumps and ventilators.
The market in Asia-Pacific is expected to register a steady revenue CAGR over the forecast period. Robust presence of key players in countries in the region is expected to drive market revenue growth. Rising adoption of infusion pumps among healthcare organizations to provide therapeutic treatments to cancer patients in the region, is also expected to revenue growth of the market in this region. WHO estimates suggests that Australia and New Zealand have the highest cancer rates of 452.4 and 422.9 per 100,000 people respectively. This is expected to increase adoption of infusion pump systems to provide chemotherapy, which is expected to drive market revenue growth in Asia-Pacific.
Competitive landscape of the global infusion pump market is moderately consolidated with few key players operating on global and regional levels. Key players are engaged in strategic alliances to expand their respective portfolios and gain a robust footing in the global market. Some of the major companies included in the global market report are B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International, Inc., ICU Medical, Inc., Fresenius Kabi Oncology Limited, Eitan Medical, Micrel Medical Devices, Medtronic PLC, TERUMO, Co., and Avanos Medical, Inc.
- On 06 January 2022, ICU Medical Inc. completed the acquisition of Smiths Medical from Smiths Group plc., creating a new powerhouse in infusion. This is expected to increase revenue of both firms with estimated pro forma combined revenues of about USD 2.5 billion.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional, and country-level, and provides an analysis of market trends in each sub-segment from 2022 to 2030. For the purpose of this report, Reports and Data has segmented the global infusion pump market based on product type, application, material, end-use, and region:
Infusion Pump Market Report Scope
Segments covered By Product Type Outlook, Application Outlook, Material Outlook, End-use Outlook, Regional Outlook
By Product Type Outlook
Portable Infusion Pumps
Elastomeric Infusion Pumps
Stationary Infusion Pumps
Specialty Infusion Pumps
Traditional Infusion Pumps
Implantable Infusion Pumps
Ambulatory Infusion Pumps
Syringe Infusion Pumps
Enteral Infusion Pumps
Volumetric Infusion Pumps
Consumables and Accessories
Dedicated Consumables and Accessories
Non-Dedicated Consumables and Accessories
By Application Outlook
By Material Outlook
Check Valve Seal
Electronic Hybrid Module
By End-use Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119103/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: